The p53/p63/p73 family of transcription factors: Overlapping and distinct functions

Journal of Cell Science

Volumn 113, Issue 10, 2000, Pages 1661-1670

  Levrero, M ^a   De Laurenzi, V ^b   Costanzo, A ^a   Sabatini, S ^b   Gong, J ^c   Wang, J Y J ^c   Melino, G ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; c Abl; Development; Differentiation; DNA damage; p53; p63; p73

Indexed keywords

DNA BINDING PROTEIN; PROTEIN P53; PROTEIN P73; TRANSCRIPTION FACTOR;

APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CLEFT FACE; DNA DAMAGE; ECTODERMAL DYSPLASIA; ECTRODACTYLY; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; MOUSE; NEUROBLASTOMA; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FAMILY; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0034079520     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (19)

1. Agami, R., Blandino, G., Oren, M. and Shaul, Y. (1999). Interaction of c-Abl and p73 and their collaboration to induce apoptosis. Nature 399, 809-813.
2. Amundson, S. A., Mjers, T. G. and Fornace, A. J. Jr (1998). Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogens 17, 3287-3299.
3. Arrowsmith, C. H. (1999). Structure and function in the p53 family. Cell Death Differ. 6, 1169-1173.
4. Balint, E., Bates, S. and Vousden, K. H. (1999). Mdm2 binds p73 alpha without targeting degradation. Oncogene 18, 3923-3929.
5. Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B. and Wang, J. Y. (1997). Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516-519.
6. Casciano, I., Ponzoni, M., Cunsolo, C., Tonini, G. and Romani, M. (1999). Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma. Cell Death Differ. 6, 391-393.
7. Celli, J., Duijf, P., Hamel, B. C. J., Bamshad, M., Kramer, B., Smits, A. P. T., Newbury-Ecob, R., Hennekam, R. C. M., Van Buggenhout, G., Van Haeringen, A., Woods, C. G., Van Essen, A. J., De Waal, R., Vriend, G., Haber, D. A., Yang, A., McKeon, F., Brunner, H. G. and Van Bokhoven, H. (1999). Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99, 143-153.
8. Chi, S.-W., Ayeda, A. and Arrowsmith, C. H. (1999). Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain. EMBO J. 18, 4438-4445.
9. Cho, Y., Gorina, S., Jeffrey, P. D. and Pavletich, N. P. (1994). Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355.
10. Choisy-Rossi, C. and Yonish-Rouach, E. (1998). Apoptosis and the cell cycle: the p53 connection. Cell Death Differ. 5, 129-131.
11. Davison, T. S., Vagner, C., Kaghad, M., Ayed, A., Caput, D. and Arrowsmith, C. H. (1999). p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J. Biol. Chem. 274, 18709-18714.
12. De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M. and Melino, G. (1998). Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med. 188, 1763-1768.
13. De Laurenzi, V., Catani, M. V., Costanzo, A., Terrinoni, A., Corazzari, M., Levrero, M., Knight, R. A. and Melino, G. (1999). Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta. Cell Death Differ. 6, 389-390.
14. De Laurenzi, V., Raschella', G., Barcaroli, D., Annicchiarico-Petruzzelli, M., Ranalli, M., Catani, M. V., Tanno, B., Costanzo, A., Levrero, M. and Melino, G. (2000). Induction of neuronal differentiation by p73, in a neuroblastoma cell line. J. Biol. Chem. (in press).
15. Di Como, C. J., Gaiddon, C. and Prives, C. (1999). p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol. Cell. Biol. 19, 1438-1449.
16. Ding, Y., Inoue, T., Kamiyama, J., Tamura, Y., Ohtani-Fujita, N., Igata, E. and Sakai, T. (1999). Molecular cloning and functional characterization of the upstream promoter region of the human p73 gene. DNA Res. 6, 347-351.
17. Dobbelstein, M. and Roth, J. (1998). The large T antigen of simian virus 40 binds and inactivates p53 but not p73. J. Gen. Virol. 79, 3079-3083.
18. Dobner, T., Horikoshi, N., Rubenwolf, S. and Shenk, T. (1996). Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272, 1470-1473.
19. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A. Jr, Butel, J. S., Bradley. A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221